Here’s a yard stick for Operation Warp Speed
In normal times, it takes just over six years to test novel antivirals and get them past the FDA, according to a new analysis. Now, as the Covid-19 crisis has scientists and governments racing to develop medicines, that figure provides a way to measure their success.
As STAT’s Ed Silverman reports, the analysis comes from the Tufts Center for the Study of Drug Development, which looked at all anti-infective medicines approved between 2000 and 2019, which includes antibiotics, antiparasitics, and antifungals. Those drugs arrived slightly faster than other types of medicines, but development was invariably a years-long process.
The research provides a useful baseline for judging Operation Warp Speed, the federal effort to rapidly find new treatments and vaccines for Covid-19. The FDA is yet to approve a novel antiviral for SARS-CoV-2, but when it does, we’ll know roughly how much time extraordinary measures saved.
Read more.
As STAT’s Ed Silverman reports, the analysis comes from the Tufts Center for the Study of Drug Development, which looked at all anti-infective medicines approved between 2000 and 2019, which includes antibiotics, antiparasitics, and antifungals. Those drugs arrived slightly faster than other types of medicines, but development was invariably a years-long process.
The research provides a useful baseline for judging Operation Warp Speed, the federal effort to rapidly find new treatments and vaccines for Covid-19. The FDA is yet to approve a novel antiviral for SARS-CoV-2, but when it does, we’ll know roughly how much time extraordinary measures saved.
Read more.
.png)
No hay comentarios:
Publicar un comentario